MedPath

幸福醫藥有限公司

Ownership
-
Established
1968-02-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Compound Paracetamol and Phenylephrine Tablets

Product Name
科达琳
Approval Number
国药准字HC20140023
Approval Date
Oct 25, 2024
NMPA

Pediatric Compound Paracetamol and Phenylephrine Tablets

Product Name
儿童科达琳
Approval Number
国药准字HC20140033
Approval Date
Oct 25, 2024
NMPA

Pediatric Compound Paracetamol and Phenylephrine Tablets

Product Name
儿童科达琳
Approval Number
国药准字HC20140032
Approval Date
Oct 25, 2024
NMPA

Compound Paracetamol and Phenylephrine Tablets

Product Name
科达琳
Approval Number
国药准字HC20140022
Approval Date
Oct 25, 2024
NMPA

Compound Paracetamol and Phenylephrine Tablets

Product Name
科达琳
Approval Number
HC20140022
Approval Date
Feb 13, 2020
NMPA

Compound Paracetamol and Phenylephrine Tablets

Product Name
科达琳
Approval Number
HC20140023
Approval Date
Feb 13, 2020
NMPA

Pediatric Compound Paracetamol and Phenylephrine Tablets

Product Name
儿童科达琳
Approval Number
HC20140033
Approval Date
Sep 27, 2019
NMPA

Pediatric Compound Paracetamol and Phenylephrine Tablets

Product Name
儿童科达琳
Approval Number
HC20140032
Approval Date
Sep 27, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.